These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33971709)

  • 1. Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C.
    Pennisi G; Spatola F; DI Marco L; DI Martino V; DI Marco V
    Minerva Gastroenterol (Torino); 2021 Sep; 67(3):254-263. PubMed ID: 33971709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-acting antivirals for chronic hepatitis C.
    Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012143. PubMed ID: 28585310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct acting antivirals failure: cause and retreatment options.
    Parlati L; Pol S
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1245-1250. PubMed ID: 30791789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
    Merli M; Frigeni M; Alric L; Visco C; Besson C; Mannelli L; Di Rocco A; Ferrari A; Farina L; Pirisi M; Piazza F; Loustaud-Ratti V; Arcari A; Marino D; Sica A; Goldaniga M; Rusconi C; Gentile M; Cencini E; Benanti F; Rumi MG; Ferretti VV; Grossi P; Gotti M; Sciarra R; Tisi MC; Cano I; Zuccaro V; Passamonti F; Arcaini L
    Oncologist; 2019 Aug; 24(8):e720-e729. PubMed ID: 30552159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection: A multicenter study.
    Mancuso ME; Linari S; Santagostino E; Bartolozzi D; D'Ambrosio R; Borghi M; Lampertico P; Peyvandi F; Castaman G; Aghemo A
    Liver Int; 2020 May; 40(5):1062-1068. PubMed ID: 31876354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of direct antiviral agents (DAAs) on B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C.
    Ciancio A
    Minerva Gastroenterol (Torino); 2021 Sep; 67(3):227-233. PubMed ID: 33856146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection.
    Johnson PJ; Berhane S; Walker AJ; Gordon FH; Ryder SD; McPherson S; Sreedharan A; Ustianowski AA; Agarwal K; Mutimer D; Kumada T; Toyoda H; Irving WL;
    J Viral Hepat; 2021 Jan; 28(1):168-176. PubMed ID: 32978982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C.
    Neokosmidis G; Protopapas AA; Stogiannou D; Filippidis A; Tziomalos K
    Gastroenterol Hepatol; 2023 Jan; 46(1):58-66. PubMed ID: 35460863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection.
    Mohanty A; Salameh S; Butt AA
    Curr HIV/AIDS Rep; 2019 Oct; 16(5):389-394. PubMed ID: 31482299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy.
    Huang CF; Yu ML
    Clin Mol Hepatol; 2020 Jul; 26(3):251-260. PubMed ID: 32188235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals.
    Chhatwal J; He T; Lopez-Olivo MA
    Pharmacoeconomics; 2016 Jun; 34(6):551-67. PubMed ID: 26748919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immune responses, PI3K/AKT and JAK/STAT signaling pathways following hepatitis C virus eradication by direct-acting antiviral therapy among Egyptian patients: a case control study.
    Ramadan HK; Badr G; Ramadan NK; Sayed A
    Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33524139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals.
    Liu CH; Lee MH; Lin JW; Liu CJ; Su TH; Tseng TC; Chen PJ; Chen DS; Kao JH
    J Hepatol; 2020 May; 72(5):839-846. PubMed ID: 31790766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals.
    Corma-Gómez A; Macías J; Téllez F; Freyre-Carrillo C; Morano L; Rivero-Juárez A; Ríos MJ; Alados JC; Vera-Méndez FJ; Merchante N; Palacios R; Granados R; Merino D; De Los Santos I; Pineda JA
    Clin Infect Dis; 2020 Dec; 71(9):2354-2362. PubMed ID: 31754695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
    Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
    Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
    Lam L; Fontaine H; Lapidus N; Dorival C; Bellet J; Larrey D; Nahon P; Diallo A; Cagnot C; Lusivika-Nzinga C; Téoulé F; Hejblum G; Bourlière M; Pol S; Carrat F;
    Pharmacoepidemiol Drug Saf; 2023 Apr; 32(4):486-495. PubMed ID: 36444965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.
    Béguelin C; Suter A; Bernasconi E; Fehr J; Kovari H; Bucher HC; Stoeckle M; Cavassini M; Rougemont M; Schmid P; Wandeler G; Rauch A;
    Liver Int; 2018 Mar; 38(3):424-431. PubMed ID: 28741901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.
    Chhatwal J; Chen Q; Ayer T; Bethea ED; Kanwal F; Kowdley KV; Wang X; Roberts MS; Gordon SC
    Aliment Pharmacol Ther; 2018 Apr; 47(7):1023-1031. PubMed ID: 29377245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.